Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
This Month's Featured Article 3 "Forever Stocks" to Hold When the Market Won't Sit StillAuthor: Chris Markoch. Posted: 1/19/2026. 
Summary - Chevron provides long-term income potential through disciplined buybacks, a growing dividend, and exposure to global energy markets.
- Colgate-Palmolive delivers consistency with a diversified brand portfolio and more than six decades of annual dividend increases.
- Merck combines near-term cash flow from Keytruda with a late-stage oncology pipeline aimed at sustaining future growth.
With so much volatility in the market, it’s a good time for investors to consider stocks they can hold for the long haul. These compounders don’t need to make up a large portion of your portfolio, but they’re useful for investors who prefer to step away from their screens. Owning "forever stocks" is about more than chasing the next hot trade. It means building a portfolio around companies with durable competitive advantages, resilient cash flows, and shareholder-friendly capital allocation. These are the businesses that can weather economic cycles, adapt to industry shifts, and continue rewarding investors through dividends and long-term appreciation. Recent algorithm alerts have flagged stocks like Nuburu, MSS, and Rebel Holdings ahead of sharp moves — including triple-digit gains in a short time frame. These signals all came from Tim Bohen's new system, called The Monday Algo, which scans the market each week for early breakout setups.
Now, the algorithm is highlighting a new low-priced stock heading into Monday. While no trade is guaranteed, Tim is breaking down why this setup stands out — and how he and his students approach these Monday momentum opportunities. See the latest Monday Algo setup here Large-cap leaders with global footprints often fit this profile. They benefit from scale, strong brands, and balance sheets that allow them to invest through downturns while returning capital to shareholders. While even the best companies can experience periods of underperformance, history shows patience is often rewarded when the underlying business remains strong. Chevron: Energy Income With Long-Term Staying Power Chevron Corp. (NYSE: CVX) is a large-cap name among energy stocks. The company is an integrated oil giant with significant exposure to the Permian Basin and several deep-water projects, and it also has investments in renewable energy. CVX's stock price is sensitive to fluctuations in the price of oil. That sensitivity helps explain why the stock has produced a total return of just 5.1% over the last three years. Even though oil production is near record levels, crude prices in the high $50s to low $60s have pressured earnings. But this piece focuses on owning forever stocks over long horizons. Over the past 10 years, CVX has delivered a total return of more than 200%. The company has a track record of share buybacks and a growing, well-covered dividend. The yield at the time of writing is about 4.12%. More important may be the annualized payout of $6.84 per share and Chevron’s status as a dividend aristocrat with 38 consecutive years of dividend increases. Colgate-Palmolive: A Dividend King Built for Consistency Colgate-Palmolive Co. (NYSE: CL) is a leading name among consumer staples stocks. The company owns a deep portfolio of brands with global reach. The bullish case for CL often traces back to Peter Lynch’s advice to "own what you know" — these are everyday products with stable, long-term demand that most investors understand. That said, recent holders have had a bumpy ride. This "forever" stock has generated a total return of roughly 15% over the past five years, which includes the company’s dividend, yielding about 2.47%. Over longer time frames, however, CL has been a reliable compounder and a wealth builder thanks to its status as a dividend king. The company has increased its dividend for 63 consecutive years. At roughly 22 times earnings, the stock also looks reasonably valued relative to its history and the broader market. Merck: Pipeline-Driven Growth Beyond Keytruda Merck & Co. (NYSE: MRK) was volatile in 2025, falling to about $72 — roughly 45% below its June 2024 high. Like the other names here, MRK has been a challenging hold recently, delivering a total return of just over 10% in the past three years. Merck currently relies on its blockbuster cancer drug Keytruda for just under half of its revenue. Keytruda doesn’t face a patent cliff until 2028, but institutional investors are forward-looking and want confidence in how the company will replace that revenue. The situation is reminiscent of what AbbVie Inc. (NYSE: ABBV) faced with Humira — and AbbVie ultimately found ways to offset the decline. Merck needs to demonstrate a similar path. There is reason for optimism: Merck is pursuing additional approvals for Keytruda in new indications and has 16 oncology drugs in late-stage trials. If even one or two of those are approved in the next couple of years, they could materially offset any revenue shortfall. All three names illustrate the trade-off of owning forever stocks: short-term volatility and periodic underperformance in exchange for durable cash flows, shareholder returns, and the potential for long-term compounding. For investors willing to be patient, these kinds of businesses can form the backbone of a low-maintenance, long-term portfolio.
| 
